AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular CarcinomaEslam E. Abd El-Fattah|Frontiers in Pharmacology|2022Cited by 27